Birchtech's thesis stands on a real $78.4M judgment, but the 350% upside is a bull case with the appeal still alive
Asked (summary)
“Is this valid?” — regarding a September 28, 2026 Birchtech Corp. (BCHT) investment thesis claiming roughly 350% upside from a $42 million market cap, $11.8 million cash and no debt, a $78.4 million CERT patent judgment, a separate Ameren claim, an undervalued legacy air business, a new water business, and a $5 million buyback.
This audit checks 18 load-bearing claims of the thesis against an evidence ledger of 120 source-linked facts drawn from USPTO PTAB records, Federal Circuit docket entries and court filings (January 2025 – July 2026). Verdict: 6 claims confirmed or substantially supported, 6 partly correct or misleading, 3 speculative scenarios presented as values, and 3 unsupported — so the thesis is not valid as an investment-grade 350%-upside conclusion without major qualification. Review conducted from live web results on September 28, 2026; most rows come from USPTO records, with the appeal docket independently reported, and several financial and collection-status figures remain company-originated.
Claim audit: every load-bearing claim, sorted by how well the record supports it
Bar length shows the audit's support score (0 = no support in the record, 100 = fully documented). Hover or tap a claim for the finding and source.
Confirmed / substantially supportedPartly correct or misleadingSpeculative scenario stated as valueUnsupported
From the $42M market cap to the thesis's sum of the parts
$ million. Solid = stated or arithmetic-checked; hatched = contingent scenario, not cash or an award. Ameren shown at the author's $50–100M midpoint.
Risk waterfall: what stands between the $78.4M judgment and net cash
The thesis's own scenario path, with each unresolved risk on the way down. Only the first bar is an entered judgment; everything after it is assumption.
The defendants' Federal Circuit appeal of the infringement judgment (No. 26-1403) was docketed February 2, 2026 and briefing has been extended to August 28, 2026 — terminating the PTAB validity reviews did not dismiss it. dockets.justia.com
The judgment rests on a real record: a Delaware jury trial (Feb 26 – Mar 1, 2024) and judgment following the verdict in C.A. 1:19-cv-01334, with defendants' post-trial motion for judgment as a matter of law denied. ptacts.uspto.gov
The validity siege was heavy but is over: 17 inter partes reviews were filed against 6 patents in one family between January 17 and July 18, 2025, and a precedential January 12, 2026 Director decision plus settlements and termination motions closed them out. ptacts.uspto.gov
The Ameren case (4:24-cv-00980, E.D. Mo.) is a filed complaint, nothing more — the thesis's $50–100M value for it is an author-built damages scenario, not an award or settlement. ptacts.uspto.gov
Evidence ledger: 120 source-linked facts
Sorted newest first by date or period. Each row links its source document.
Date / period
Topic
Fact
Status / caveat
Source
Method: audit of a September 28, 2026 BCHT investment thesis against 120 source-linked factual claims from USPTO PTAB filings, Federal Circuit docket entries and court records, collected from live web results on September 28, 2026. The 18-claim audit scores are the reviewer's judgment of documentary support, not probabilities. Dollar figures in the bridge and waterfall restate the thesis's own numbers ($ million) and are labeled contingent where no award, collection or repurchase is evidenced. Long facts and statuses are truncated for space; evidence excerpts were cut.